Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View ANIX insider activity ↗

ANIXAnixa Biosciences Inc

THE LATEST REPORTED YEAR

The company reported a loss.

$10.93M net loss for the year ended October 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$210KYear ended October 31, 2024
Profit or loss-$10.93MYear ended October 31, 2025
Cash from the business-$7.17MYear ended October 31, 2025
Total assets$15.07MAs of July 31, 2026
Total liabilities$1.87MAs of July 31, 2026
Cash & equivalents$1.4MAs of July 31, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$300K
2016-10
$362.5K
2017-10
$1.11M
2018-10
$250K
2019-10
$512K
2021-10
$210K
2023-10
$210K
2024-10

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
November 1, 2023 – October 31, 2024$210,000January 10, 202510-K ↗
November 1, 2022 – October 31, 2023$210,000January 16, 202410-K ↗
November 1, 2020 – October 31, 2021$512,000January 4, 202310-K ↗
November 1, 2018 – October 31, 2019$250,000January 7, 202110-K ↗
November 1, 2017 – October 31, 2018$1,112,500January 9, 202010-K ↗
November 1, 2016 – October 31, 2017$362,500January 11, 201910-K ↗
November 1, 2015 – October 31, 2016$300,000January 9, 201810-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:Revenues · Retrieved October 7, 2026

Response SHA-256: e81922dde8f95b9a18ad34411c18fef0305fc9d48fc76607e8e3e2758178634a

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.